Skip to main content
INTERNATIONAL BIOTECHNOLOGY TST PLC logo

INTERNATIONAL BIOTECHNOLOGY TST PLC — Investor Relations & Filings

Ticker · IBT ISIN · GB0004559349 LEI · 213800N1QUJ744P76D11 IL Financial and insurance activities
Filings indexed 4,603 across all filing types
Latest filing 2026-05-01 Regulatory Filings
Country GB United Kingdom
Listing IL IBT

About INTERNATIONAL BIOTECHNOLOGY TST PLC

https://www.ibtplc.com/

International Biotechnology Trust PLC is an investment trust that provides investors with access to the biotechnology and life sciences sectors. Its primary objective is to achieve long-term capital growth through an actively managed, diversified portfolio. The trust invests in a range of approximately 100 quoted and unquoted companies, from development to late-stage. A key aspect of its strategy is a focus on risk management, particularly ahead of significant company-specific events. Additionally, the trust aims to provide a reliable source of income, paying a biannual dividend equivalent to 4% of its net asset value.

Recent filings

Filing Released Lang Actions
Net Asset Value(s)
Regulatory Filings
2026-05-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2026-05-01 English
Net Asset Value(s)
Regulatory Filings
2026-04-30 English
Portfolio company KalVista acquired by Chiesi
M&A Activity Classification · 1% confidence The document is a regulatory news service (RNS) announcement by International Biotechnology Trust PLC concerning the acquisition of its portfolio company KalVista by Chiesi, detailing the transaction terms, premium, and impact on NAV. It is clearly an announcement of an M&A transaction (takeover bid), fitting the M&A Activity category.
2026-04-29 English
Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document is an RNS announcement titled “Net Asset Values” from International Biotechnology Trust PLC, providing unaudited NAV per share figures for specific dates. This matches the definition of a regular Net Asset Value update for an investment fund, which corresponds to category 22 (NAV).
2026-04-29 English
Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document is an RNS announcement from International Biotechnology Trust plc providing unaudited net asset values per share (Cum Income and Ex Income) for a specific date. It clearly matches the definition of a regular update of Net Asset Value (NAV) for an investment fund.
2026-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.